Chimeric antigen receptor (CAR) T-cell therapy
A type of immunotherapy that genetically engineers a patient's own T cells to recognise and destroy cancer cells.
What it is
Chimeric antigen receptor (CAR) T-cell therapy is a type of treatment that uses a patient's own immune system to fight cancer. It involves taking T cells, a type of immune cell, from the patient's blood and genetically modifying them to recognize and attack cancer cells. This modified T cell is then returned to the patient's body, where it can help destroy cancer cells.
How it works
The modified T cells are designed to recognize specific proteins on the surface of cancer cells. When these T cells encounter cancer cells with the same protein, they can attach to the cell and release chemicals that kill the cancer cell. This process can help reduce the size of a tumor and slow the growth of cancer. In some cases, this treatment can even lead to a complete disappearance of cancer cells.
Why it matters
Understanding CAR T-cell therapy is important for patients and families affected by cancer, as it is a treatment option that can be used in some cases to help manage certain types of cancer. Researchers are also studying CAR T-cell therapy to learn more about how it works and how it can be improved, which may lead to new treatment options for patients in the future.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional for guidance on your health.